Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:DOZR NYSEARCA:KPRO NASDAQ:SKYU NYSEARCA:THNR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDOZRDirexion Daily US Infrastructure Bull 2X Shares$30.65$30.65$20.87▼$32.10$3.07M2.081,536 shsN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETF$28.74-0.1%$28.52$25.76▼$28.92$2.87M0.321,229 shs150 shsSKYUProShares Ultra Nasdaq Cloud Computing ETF$32.06-7.1%$32.86$17.38▼$43.79$2.89M2.132,776 shs950 shsTHNRAmplify Weight Loss Drug & Treatment ETF$22.58+0.6%$22.88$18.56▼$28.19$2.94MN/A1,811 shs1,303 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDOZRDirexion Daily US Infrastructure Bull 2X Shares0.00%0.00%0.00%0.00%0.00%KPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETF-0.07%+0.31%+0.35%+2.39%+10.50%SKYUProShares Ultra Nasdaq Cloud Computing ETF-7.06%-9.53%-4.23%+19.87%+33.16%THNRAmplify Weight Loss Drug & Treatment ETF+0.58%-5.32%-1.74%+1.71%-14.27%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDOZRDirexion Daily US Infrastructure Bull 2X SharesN/AN/AN/AN/AN/AN/AN/AN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/AN/AN/AN/AN/AN/AN/AN/ASKYUProShares Ultra Nasdaq Cloud Computing ETFN/AN/AN/AN/AN/AN/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDOZRDirexion Daily US Infrastructure Bull 2X Shares 0.00N/AN/AN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETF 0.00N/AN/AN/ASKYUProShares Ultra Nasdaq Cloud Computing ETF 2.72Moderate Buy$32.06N/ATHNRAmplify Weight Loss Drug & Treatment ETF 2.54Moderate Buy$22.58N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDOZRDirexion Daily US Infrastructure Bull 2X SharesN/AN/AN/AN/AN/AN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/AN/AN/AN/AN/AN/ASKYUProShares Ultra Nasdaq Cloud Computing ETFN/AN/AN/AN/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDOZRDirexion Daily US Infrastructure Bull 2X SharesN/AN/A8.83∞N/AN/AN/AN/AN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/AN/A16.73∞N/AN/AN/AN/AN/ASKYUProShares Ultra Nasdaq Cloud Computing ETFN/AN/A29.23∞N/AN/AN/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AN/A24.31∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDOZRDirexion Daily US Infrastructure Bull 2X Shares$0.200.65%N/AN/AN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETF$0.993.44%N/AN/AN/ASKYUProShares Ultra Nasdaq Cloud Computing ETF$0.080.25%N/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETF$0.220.97%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDOZRDirexion Daily US Infrastructure Bull 2X SharesN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/ASKYUProShares Ultra Nasdaq Cloud Computing ETFN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AInsider OwnershipCompanyInsider OwnershipDOZRDirexion Daily US Infrastructure Bull 2X SharesN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/ASKYUProShares Ultra Nasdaq Cloud Computing ETFN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDOZRDirexion Daily US Infrastructure Bull 2X SharesN/A100,000N/ANot OptionableKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/A100,000N/AN/ASKYUProShares Ultra Nasdaq Cloud Computing ETFN/A90,000N/AOptionableTHNRAmplify Weight Loss Drug & Treatment ETFN/A130,000N/AN/ATHNR, SKYU, DOZR, and KPRO HeadlinesRecent News About These CompaniesWeight Loss Drug ETF (THNR) Hits New 52-Week HighJune 2, 2025 | zacks.comNew Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFsJanuary 17, 2025 | etftrends.comEDisruptive Theme of the Week – Breakthroughs in MedicineNovember 21, 2024 | etftrends.comEAmplify ETFs Hits $10 Billion in Assets Amid New ETF LaunchesOctober 29, 2024 | etftrends.comETap the Weight-Loss Drug Market With These ETFsSeptember 18, 2024 | zacks.comDisruptive Theme of the Week: Playing DefenseAugust 14, 2024 | etftrends.comEETFs in Focus as Competition Heats Up in Weight Loss Drug SegmentJuly 22, 2024 | zacks.comTop Themes in the First Half of 2024: Crypto, Chips, Ships & SilverJuly 2, 2024 | etftrends.comEWhy Investors Haven't Feasted on Two New Weight-Loss ETFsJune 24, 2024 | investopedia.comFinding Opportunity in Unloved Healthcare ETFsMay 31, 2024 | etftrends.comEPlay These New ETFs to Tap Lucrative Weight Loss Drug MarketMay 22, 2024 | zacks.comMedia Sentiment Over TimeTHNR, SKYU, DOZR, and KPRO Company DescriptionsDirexion Daily US Infrastructure Bull 2X Shares NYSEARCA:DOZR$30.65 0.00 (0.00%) As of 02/24/2023The Direxion Daily US Infrastructure Bull 2X Shares (DOZR) is an exchange-traded fund that is based on the Indxx US Infrastructure index. The fund provides daily 2x leveraged exposure to an equal-weighted index of 100 US infrastructure companies. DOZR was launched on Sep 23, 2021 and is managed by Direxion.KraneShares 100% KWEB Defined Outcome Through January 2026 ETF NYSEARCA:KPRO$28.74 -0.02 (-0.07%) As of 08/1/2025 04:10 PM EasternThe KraneShares 100% KWEB Defined Outcome January 2026 ETF (KPRO) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund seeks to track the total return of the KraneShares CSI China Internet ETF (KWEB) up to a cap, with a 100% downside hedge over a two-year outcome period. The actively managed fund holds shares of the underlying ETF and options to obtain exposure KPRO was launched on Feb 8, 2024 and is issued by KraneShares.ProShares Ultra Nasdaq Cloud Computing ETF NASDAQ:SKYU$32.06 -2.44 (-7.06%) Closing price 08/1/2025 03:56 PM EasternExtended Trading$32.81 +0.75 (+2.33%) As of 08/1/2025 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The ProShares Ultra Cloud Computing (SKYU) is an exchange-traded fund that is based on the ISE Cloud Computing index. The fund provides 2x leveraged exposure to a modified-equally-weighted index of US companies in the cloud computing industry. SKYU was launched on Jan 19, 2021 and is managed by ProShares.Amplify Weight Loss Drug & Treatment ETF NYSEARCA:THNR$22.58 +0.13 (+0.58%) As of 08/1/2025 04:10 PM EasternThe Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that is based on the VettaFi Weight Loss Drug index. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
